Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Accentia Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of late-stage clinical products in the therapeutic areas of respiratory disease and oncology. Two of these products are SinuNase(TM) and BiovaxID(TM). The Company’s SinuNase product, in development to treat chronic sinusitis (rhinosinusitis), is a novel application and formulation of a known anti-fungal licensed from the Mayo Foundation for Medical Education and Research. BiovaxID is a patient-specific anti-cancer vaccine for the treatment of follicular non-Hodgkin’s lymphoma. BiovaxID, which is being developed by Accentia subsidiary Biovest International, Inc., is currently in a Phase 3 clinical ( www.accentia.net )
Accentia Biopharmaceuticals , Inc.
324 South Hyde Park Ave Suite 350
Tampa, Florida 33606
USA
Tel: (813) 864-2562
Fax: (813) 258-6912